A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR FLUORIDE UPTAKE BY BONE

被引:24
|
作者
RAO, HV
BELILES, RP
WHITFORD, GM
TURNER, CH
机构
[1] US EPA,WASHINGTON,DC 20460
[2] MED COLL GEORGIA,DEPT ORAL BIOL,AUGUSTA,GA 30912
[3] INDIANA SCH MED,DEPT ORTHOPED SURG,INDIANAPOLIS,IN 46202
关键词
D O I
10.1006/rtph.1995.1065
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
A sex-specific, physiologically based pharmacokinetic (pbpk) model has been developed to describe the absorption, distribution, and elimination of fluorides in rats and humans. Growth curves generated by plotting mean body weights (kg) against age (weeks or years) are included in the simulation model to allow the integration of chronic fluoride exposure from birth to old age. The model incorporates age and body weight dependence of the physiological processes that control the uptake of fluoride by bone and the elimination of fluoride by the kidneys. Six compartments make up the model. These are lung, liver, kidney, bone, and slowly and rapidly perfused compartments. The model also includes two bone subcompartments: a small, flow-limited, rapidly exchangeable surface bone compartment and a bulk virtually nonexchangeable inner bone compartment. The inner bone compartment contains nearly all of the whole body content of fluoride, which, in the longer time frame, may be mobilized through the process of bone modeling and remodeling. The model has been validated by comparing the model predictions with experimental data gathered in rats and humans after drinking water and dietary ingestion of fluoride. This physiological model description of absorption, distribution, and elimination of fluoride from the body permits the analysis of the combined effect of ingesting and inhaling fluorides on the target organ, bone. Estimates of fluoride concentrations in bone are calculated and related to chronic fluoride toxicity. The model is thus useful for predicting some of the long-term metabolic features and tissue concentrations of fluoride that may be of value in understanding positive or negative effects of fluoride on human health. In addition, the pbpk model provides a basis for across-species extrapolation of the effective fluoride dose at the target tissue, bone, in the assessment of risk from different exposure conditions. (C) 1995 Academic Press, Inc.
引用
收藏
页码:30 / 42
页数:13
相关论文
共 50 条
  • [21] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR DESETHYLAMIODARONE
    HOU, ZY
    BALTER, NJ
    WOOSLEY, RL
    SCHWARTZ, SL
    CIRCULATION, 1990, 82 (04) : 196 - 196
  • [22] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Lyndsey F. Meyer
    Pooja M. Rajadhyaksha
    Dhaval K. Shah
    Journal of Pharmacokinetics and Pharmacodynamics, 2022, 49 : 325 - 336
  • [23] Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
    Ai, Jing
    Gao, Yunfeng
    Yang, Fan
    Zhao, Zhen
    Dong, Jin
    Wang, Jing
    Fu, Shiyi
    Ma, Ying
    Gu, Xu
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [24] Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia
    Lee, Joomi
    Kim, Min-Gul
    Jeong, Hyeon-Cheol
    Shin, Kwang-Hee
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (01) : 33 - 44
  • [25] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY ORGANOPHOSPHATE ESTERS
    GEARHART, JM
    JEPSON, GW
    CLEWELL, HJ
    ANDERSEN, ME
    CONOLLY, RB
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 51 - 60
  • [26] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [27] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Meyer, Lyndsey F.
    Rajadhyaksha, Pooja M.
    Shah, Dhaval K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2022, 49 (03) : 325 - 336
  • [28] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ABSORPTION OF ORAL PARACETAMOL IN MAN
    CLEMENTS, JA
    NIMMO, WS
    HEADING, RC
    PRESCOTT, LF
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 : P60 - P60
  • [29] PREDICTION OF ANTICHOLINESTERASE ACTIVITY AND URINARY METABOLITES OF ISOFENPHOS - USE OF A PERCUTANEOUS PHYSIOLOGICALLY-BASED PHARMACOKINETIC PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODEL
    KNAAK, JB
    ALBAYATI, MA
    RAABE, OG
    BLANCATO, JN
    BIOMARKERS OF HUMAN EXPOSURE TO PESTICIDES, 1994, 542 : 284 - 300